Author:
Jiang Xi-fei,Dai Yang,Peng Xia,Shen Yan-yan,Su Yi,Wei Man-man,Liu Wei-ren,Ding Zhen-bin,Zhang Ao,Shi Ying-hong,Ai Jing
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference30 articles.
1. Turner N, Grose R . Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 2010; 10: 116–29.
2. Dieci MV, Arnedos M, Andre F, Soria JC . Fibroblast growth factor receptor inhibitors as a cancer treatment: from a biologic rationale to medical perspectives. Cancer Discov 2013; 3: 264–79.
3. Touat M, Ileana E, Postel-Vinay S, Andre F, Soria JC . Targeting FGFR Signaling in Cancer. Clin Cancer Res 2015; 21: 2684–94.
4. Babina IS, Turner NC . Advances and challenges in targeting FGFR signalling in cancer. Nat Rev Cancer 2017; 17: 318–32.
5. Yang W, Yao YW, Zeng JL, Liang WJ, Wang L, Bai CQ, et al. Prognostic value of FGFR1 gene copy number in patients with non-small cell lung cancer: a meta-analysis. J Thoracic Dis 2014; 6: 803–9.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献